Mười câu hỏi và mười câu trả lời để làm rõ “hộp đen” của nhà tạo lập thị trường: Tại sao các nhà đầu tư mạo hiểm lại tham gia vào hoạt động tạo lập thị trường? Liệu chủ dự án có thực sự dễ bị đâm sau lưng không?

1315 Capital

company

About

1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.

  • 11 - 50

Details

Industries
Finance,Financial Services,Venture Capital
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
PE

1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and digital health. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$20 million investments in commercial healthcare entities that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.

Investments

Number of Investments
Number of Lead Investments
1
1
1315 Capital has made 1 investments. Their most recent investment was on Jul 13, 2022, when NutriSense raised $25M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 13, 2022 NutriSense
Series A $25M Apps Yes